ASGE Annual GI Advanced Practice Provider Course (On-Demand) - Clinical Case-Based Learning (Day Two)

Video Transcription

Video Summary

The video transcript provides an in-depth overview of the updates in inflammatory bowel disease (IBD) pharmacology, focusing on new treatments, including IL-23 inhibitors, small molecules, biosimilars, and new formulations. The speaker discusses differentiating features between Crohn's disease and ulcerative colitis, the importance of safety considerations, and factors influencing treatment decisions. The transcript also outlines a pyramid of safety profiles for various classes of therapy and includes practice pearls emphasizing the need for patient-centered care, shared decision-making, and considering individual characteristics when selecting IBD treatments. The speaker concludes by highlighting the diverse treatment options available and the importance of tailoring therapy to each patient's specific needs and circumstances.

Asset Subtitle

Kimberly Kearns, MS, APN-BC

Keywords

inflammatory bowel disease

pharmacology

IL-23 inhibitors

small molecules

biosimilars

Crohn's disease

ulcerative colitis

safety considerations